PTEN/MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas

Japanese Journal of Cancer Research

Volumn 91, Issue 3, 2000, Pages 287-292

  Fujiwara, Yoshiyuki ^a   Hoon, Dave S B ^c   Yamada, Terumasa ^a   Umeshita, Koji ^a   Gotoh, Mitsukazu ^a   Sakon, Masato ^a   Nishisho, Isamu ^b   Monden, Morito ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA NATIONAL HOSPITAL   (Japan)

^c JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

Hepatocellular carcinoma; LOH; Microsatellite marker; PTEN MMAC 1

Indexed keywords

DINUCLEOTIDE; MICROSATELLITE DNA;

ALLELE; ARTICLE; CHROMOSOME 10Q; CHROMOSOME DELETION; CHROMOSOME MAP; CLINICAL ARTICLE; CONTROLLED STUDY; GENE LOCATION; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MISSENSE MUTATION; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

EID: 0034079163     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2000.tb00943.x     Document Type: Article

References (41)

1. Murakami, Y., Hayashi, K., Hirohashi, S. and Sekiya, T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res., 51, 5520-5525 (1991).
2. Zhang, X., Xu, H. J., Murakami, Y., Sachse, R., Yashima, K., Hirohashi, S., Hu, S. X., Benedict, W. F. and Sekiya, T. Deletions of chromosome 13q, mutations in retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res., 54, 4177-4182 (1994).
3. Yeh, S. H., Chen, P. J., Chen, H. L., Lai, M. Y., Wang, C. C. and Chen, D. S. Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res., 54, 4188-4192 (1994).
4. Wang, H. P. and Rogler, C. E. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet. Cell Genet., 48, 72-78 (1988).
5. Emi, M., Fujiwara, Y., Ohata, H., Tsuda, H., Hirohashi, S., Koike, M., Miyaki, M., Monden, M. and Nakamura, Y. Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma. Genes Chromosom. Cancer, 7, 152-157 (1993).
6. Takahashi, K., Kudo, J., Ishibashi, H., Hirata, Y. and Niho, Y. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma. Hepatology, 17, 794-799 (1993).
7. Nagai, H., Pineau, P., Tiollais, P., Buendia, M. A. and Dejean, A. Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene, 14, 2927-2933 (1997).
8. Piao, Z., Park, C., Park, J. H. and Kim, H. Deletion mapping of chromosome 4q in hepatocellular carcinoma. Int. J. Cancer, 79, 356-360 (1998).
9. Ding, S. F., Habib, N. A., Dooley, J., Wood, C., Bowles, L. and Delhanty, J. D. Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis. Br. J. Cancer, 64, 1083-1087 (1991).
10. Tsuda, H., Hirohashi, S., Shimosato, Y., Ino, Y., Yoshida, T. and Terada, M. Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma. Jpn. J. Cancer Res., 80, 196-199 (1989).
11. Miyoshi, Y., Iwao, K., Nagasawa, Y., Aihara, T., Sasaki, Y., Imaoka, S., Murata, M., Shimano, T. and Nakamura, Y. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res., 58, 2524-2527 (1998).
12. Petersen, S., Rudolf, J., Bockmuhl, U., Gellert, K., Wolf, G., Dietel, M. and Petersen, I. Distinct regions of allelic imbalance on chromosome 10q22-q26 in squamous cell carcinomas of the lung. Oncogene, 17, 449-454 (1998).
13. Simon, M., von, Deimling, A., Larson, J. J., Wellenreuther, R., Kaskel, P., Waha, A., Warnick, R. E., Tew, J. J. and Menon, A. G. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res., 55, 4696-4701 (1995).
14. Sonoda, Y., Murakami, Y., Tominaga, T., Kayama, T., Yoshimoto, T. and Sekiya, T. Deletion mapping of chromosome 10 in human glioma. Jpn. J. Cancer Res., 87, 363-367 (1996).
15. Speaks, S. L., Sanger, W. G., Masih, A. S., Harrington, D. S., Hess, M. and Armitage, J. O. Recurrent abnormalities of chromosome bands 10q23-25 in non-Hodgkin's lymphoma. Genes Chromosom. Cancer, 5, 239-243 (1992).
16. Zedenius, J., Wallin, G., Svensson, A., Bovee, J., Hoog, A., Backdahl, M. and Larsson, C. Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors. Hum. Genet., 97, 299-303 (1996).
17. Bose, S., Wang, S. I., Terry, M. B., Hibshoosh, H. and Parsons, R. Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas. Oncogene, 17, 123-127 (1998).
18. Cappellen, D., Gil, D. D. M. S., Chopin, D., Thiery, J. P. and Radvanyi, F. Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder. Oncogene, 14, 3059-3066 (1997).
19. Feilotter, H. F., Nagai, M. A., Boag, A. H., Eng, C. and Mulligan, L. M. Analysis of PTEN and the 10q23 region in primary prostate carcinomas. Oncogene, 16, 1743-1748 (1998).
20. Isshiki, K., Elder, D. E., Guerry, D. and Linnenbach, A. J. Chromosome 10 allelic loss in malignant melanoma. Genes Chromosom. Cancer, 8, 178-184 (1993).
21. Jones, M. H., Koi, S., Fujimoto, I., Hasumi, K., Kato, K. and Nakamura, Y. Allelotype of uterine cancer by analysis of RFLP and microsatellite polymorphisms: frequent loss of heterozygosity on chromosome, arms 3p, 9q. 10q, and 17p. Genes Chromosom. Cancer, 9, 119-123 (1994).
22. Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D. H. F. and Tavtigian, S. V. Identification of a candidate tumour suppressor gene. MMAC1. at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 15, 356-362 (1997).
23. Cairns, P., Okami, K., Halachmi, S., Halachmi, N., Esteller, M., Herman, J. G., Jen, J., Isaacs, W. B., Bova, G. S. and Sidransky, D. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res., 57, 4997-5000 (1997).
24. Cairns, P., Evron, E., Okami, K., Halachmi, N., Esteller, M., Herman, J. G., Bose, S., Wang, S. I., Parsons, R. and Sidransky, D. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers. Oncogene, 16, 3215-3218 (1998).
25. Chiariello, E., Roz, L., Albarosa, R., Magnani, I. and Finocchiaro, G. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas. Oncogene, 16, 541-545 (1998).
26. Kohno, T., Takahashi, M., Manda, R. and Yokota, J. Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancers. Genes Chromosom. Cancer, 22, 152-156 (1998).
27. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M. H. and Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275, 1943-1947 (1997).
28. Risinger, J. I., Hayes, A. K., Berchuck, A. and Barrett, J. C. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res., 57, 4736-4738 (1997).
29. Yokomizo, A., Tindall, D. J., Drabkin, H., Gemmill, R., Franklin, W., Yang, P., Sugio, K., Smith, D. I. and Liu, W. PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. Oncogene, 17, 475-479 (1998).
30. Liaw, D., Marsh, D. J., Li, J., Dahia, P. L., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacocke, M., Eng, C. and Parsons, R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet., 16, 64-67 (1997).
31. Marsh, D. J., Dahia, P. L., Zheng, Z., Liaw, D., Parsons, R., Gorlin, R. J. and Eng, C. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet., 16, 333-334 (1997).
32. Marsh, D. J., Coulon, V., Lunetta, K. L., Rocca, S. P., Dahia, P. L., Zheng, Z., Liaw, D., Caron, S., Duboue, B., Lin, A. Y., Richardson, A. L., Bonnetblanc, J. M., Bressieux, J. M., Cabarrot, M. A., Chompret, A., Demange, L., Eeles, R. A., Yahanda, A. M., Fearon, E. R., Fricker, J. P., Gorlin, R. J., Hodgson, S. V., Huson, S., Lacombe, D., LePrat, F., Odent, S., Toulouse, C., Olopade, O. I., Sobol, H., Tishler, S., Woods, C. G., Robinson, B. G., Weber, H. C., Parsons, R., Peacocke, M., Longy, M. and Eng, C. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum. Mol. Genet., 7, 507-515 (1998).
33. Japanese Liver Cancer Society. "The General Rules for Clinical and Pathological Study of Primary Liver Cancer," 3rd Ed., pp. 22-23 (1992). Kanehara Co., Tokyo.
34. Sato, T., Tanigami, A., Yamakawa, K., Akiyama, F., Kasumi, F., Sakamoto, G. and Nakamura, Y. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res., 50, 7184-7189 (1990).
35. Gyapay, G., Morissette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M. and Weissenbach, J. The 1993-94 Genethon human genetic linkage map. Nat. Genet., 7, 246-339 (1994).
36. Suzuki, H., Freije, D., Nusskern, D. R., Okami, K., Cairns, P., Sidransky, D., Isaacs, W. B. and Bova, G. S. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res., 58, 204-209 (1998).
37. Maier, D., Zhang, Z., Taylor, E., Hamou, M. F., Gratzl, O., Van, M. E., Scott, R. J. and Merlo, A. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliotnas. Oncogene, 16, 3331-3335 (1998).
38. Maehama, T. and Dixon, J. E. The tumor suppressor, PTEN/MMAC1. dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem., 273, 13375-13378 (1998).
39. Myers, M. P., Pass, I., Batty, I. H., Kaay, J. V., Stolarov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P. and Tonks, N. K. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl. Acad. Sci. USA, 95, 13513-13518 (1998).
40. Tumura, M., Gu, J., Matsumoto, K., Aota, S., Parsons, R. and Yamada, K. M. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science, 280, 1614-1617 (1998).
41. Olschwang, S., Serova-Sinilnikova, O. M., Lenoir, G. M. and Thomas, G. PTEN germ-line mutations in juvenile polyposis coli. Nat. Genet., 18, 12-14 (1998).